141 related articles for article (PubMed ID: 28952976)
1. Effects of morphine/CP55940 mixtures on an impulsive choice task in rhesus monkeys.
Minervini V; France CP
Behav Pharmacol; 2018 Feb; 29(1):60-70. PubMed ID: 28952976
[TBL] [Abstract][Full Text] [Related]
2. Effects of opioid/cannabinoid mixtures on impulsivity and memory in rhesus monkeys.
Minervini V; France CP
Behav Pharmacol; 2020 Apr; 31(2&3):233-248. PubMed ID: 32101988
[TBL] [Abstract][Full Text] [Related]
3. Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure.
Maguire DR; France CP
Psychopharmacology (Berl); 2018 Aug; 235(8):2357-2365. PubMed ID: 29860612
[TBL] [Abstract][Full Text] [Related]
4. Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.
Maguire DR; France CP
Eur J Pharmacol; 2016 Aug; 784():199-206. PubMed ID: 27184925
[TBL] [Abstract][Full Text] [Related]
5. Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.
Maguire DR; Yang W; France CP
J Pharmacol Exp Ther; 2013 Jun; 345(3):354-62. PubMed ID: 23536317
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio.
Maguire DR; France CP
Eur J Pharmacol; 2018 Jan; 819():217-224. PubMed ID: 29183835
[TBL] [Abstract][Full Text] [Related]
7. Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats.
Minervini V; Dahal S; France CP
J Pharmacol Exp Ther; 2017 Feb; 360(2):280-287. PubMed ID: 27903642
[TBL] [Abstract][Full Text] [Related]
8. Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats.
Maguire DR; France CP
Behav Pharmacol; 2016 Feb; 27(1):69-72. PubMed ID: 26292184
[TBL] [Abstract][Full Text] [Related]
9. Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.
Grenald SA; Young MA; Wang Y; Ossipov MH; Ibrahim MM; Largent-Milnes TM; Vanderah TW
Neuropharmacology; 2017 Apr; 116():59-70. PubMed ID: 28007501
[TBL] [Abstract][Full Text] [Related]
10. Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys.
Weed PF; Gerak LR; France CP
Eur J Pharmacol; 2018 Aug; 833():94-99. PubMed ID: 29807027
[TBL] [Abstract][Full Text] [Related]
11. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham SM; Angus JA; Tudor EM; Wright CE
Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
[TBL] [Abstract][Full Text] [Related]
12. Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys.
Moerke MJ; Banks ML; Cheng K; Rice KC; Negus SS
Drug Alcohol Depend; 2017 Dec; 181():85-93. PubMed ID: 29040826
[TBL] [Abstract][Full Text] [Related]
13. Effects of amphetamine, morphine, and CP 55, 940 on Go/No-Go task performance in rhesus monkeys.
Koek W; Gerak LR; France CP
Behav Pharmacol; 2015 Aug; 26(5):481-4. PubMed ID: 26061355
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.
Fischer BD; Ward SJ; Henry FE; Dykstra LA
Neuropharmacology; 2010 Feb; 58(2):544-50. PubMed ID: 19699755
[TBL] [Abstract][Full Text] [Related]
15. Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.
Gerak LR; Zanettini C; Koek W; France CP
Psychopharmacology (Berl); 2015 Oct; 232(19):3637-47. PubMed ID: 26202613
[TBL] [Abstract][Full Text] [Related]
16. Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.
Maguire DR; France CP
J Pharmacol Exp Ther; 2014 Nov; 351(2):383-9. PubMed ID: 25194020
[TBL] [Abstract][Full Text] [Related]
17. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
18. Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats.
Moerke MJ; Negus SS
Neuropharmacology; 2019 Jun; 151():180-188. PubMed ID: 30880123
[TBL] [Abstract][Full Text] [Related]
19. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of morphine on distinct forms of impulsive behavior in rats.
Pattij T; Schetters D; Janssen MC; Wiskerke J; Schoffelmeer AN
Psychopharmacology (Berl); 2009 Aug; 205(3):489-502. PubMed ID: 19436995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
